Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices
M. Bartoletti & S. Pignata et al.
· 2021-04-27
Links
DOI
PubMed
Journal
ESMO Open
Authors
M. Bartoletti
,
S.C. Cecere
,
L. Musacchio
,
R. Sorio
,
F. Puglisi
,
S. Pignata